CRBN and cancer: PROTACs recruiting the cereblon E3 ligase have successfully induced the forced degradation of more than 60 different proteins, associated with the development of a wide range of disorders, from cancer to neurological, immunological and viral diseases, with successful examples already in clinical trials54–58.